Copyright
©The Author(s) 2023.
World J Transplant. Sep 18, 2023; 13(5): 276-289
Published online Sep 18, 2023. doi: 10.5500/wjt.v13.i5.276
Published online Sep 18, 2023. doi: 10.5500/wjt.v13.i5.276
Table 1 Definitions of terms used to describe the living donors at different stages of kidney donation including access, counseling, evaluation, acceptance, candidacy, and donation with kidney transplantation of related intended patients
Term | Definition |
PLD | An individual who confirmed his willingness to donate a kidney to an intended patient at the initial counseling settings and was ready to start the evaluation for kidney donation, regardless of the commencement of the evaluation |
Related PLD | PLD who had a relative intended patient with end-stage renal disease up to the 4th degree of genetic relatedness. Regardless of their genetic relatedness, the wife or husband of a recipient was considered a related PLD |
Excluded PLD | PLD who was disqualified as a kidney donor and excluded from the process of kidney donation by KT team due to causes that disqualify candidacy to donate a kidney, such as medical, immunological, or financial causes |
Regressed PLD | PLD who withdrew his decision of kidney donation at any stage after an initial confirmation of the donation decision and before the operation |
Released PLD1 | PLD who was still willing and completed or was still continuing the evaluation, but the related intended patient was withdrawn from KT preparation due to any cause |
Candidate PLD | PLD who completed all the steps of evaluation and was finally accepted by the KT team for kidney donation, regardless of the later regression or release from donation |
Accepted PLD | PLD who completed the evaluation without exclusion from kidney donation and was accepted for donation without release or regression from his willingness |
LD | PLD becomes a LD when he succeeds in donating a kidney to his/her intended patient, which also means KT was achieved |
Relatedness degrees and forms2 | First degree: father, mother, son, daughter, wife, and husband. Second degree: brother, sister, grandfather, grandmother, grandson, and granddaughter. Third degree: nephew, uncle and aunt. Fourth degree: cousins |
Table 2 Demographic and clinical characteristics of patients and related potential living donors presented as total patients (n = 212) and as a comparison between patients with candidate (n = 74) and patients with non-candidate (n = 138) potential living donors
Characteristics | Total patients, n = 212 | Patients with candidate PLDs, n = 74 | Patients with non-candidate PLDs, n = 138 | P value |
mean ± SD (range)/number (%) | ||||
Mean age in yr | 31.2 ± 10.6 (13-66) | 29.1 ± 9.6 (13-57) | 32.9 ± 12.0 (14-66) | 0.041 |
Sex, n = 212 | ||||
Males | 173 (81.6%) | 67 (90.5%) | 106 (76.8%) | 0.087 |
Females | 39 (18.4%) | 7 (9.5%) | 32 (23.2%) | |
Status of dialysis at presentation, n = 212 | ||||
Preemptive | 19 (9.0%) | 5 (6.8%) | 14 (10.1%) | 0.462 |
On regular hemodialysis | 193 (91.0%) | 69 (93.2%) | 124 (89.9%) | |
Primary kidney disease, n = 212 | ||||
Unknown | 167 (78.8%) | 56 (75.7%) | 111 (80.4%) | 0.088 |
Systemic disease | 14 (6.6%) | 3 (2.7%) | 11 (8.0%) | |
Glomerulonephritis | 6 (2.8%) | 3 (4.0%) | 3 (2.2%) | |
Hereditary renal disease | 5 (3.8%) | 2 (2.7%) | 3 (2.2%) | |
Obstructive uropathy | 11 (5.2%) | 8 (10.8%) | 3 (2.2%) | |
Urolithiasis | 9 (4.2%) | 2 (2.7%) | 7 (5.1%) | |
Categories of primary kidney disease, n = 212 | ||||
Unknown | 167 (78.8%) | 56 (75.7%) | 111 (80.4%) | 0.154 |
Systemic disease | 14 (6.6%) | 3 (4.0%) | 11 (8.0%) | |
Local, renal/urinary | 31 (14.6%) | 15 (20.3%) | 16 (11.6%) | |
Patients per number of PLDs, n = 212 | ||||
Patients with one PLD | 165 (77.8%) | 53 (71.6%) | 112 (81.2%) | 0.265 |
Patients with two PLDs | 39 (18.4%) | 17 (23.0%) | 22 (15.9%) | |
Patients with three PLDs | 8 (3.8%) | 4 (5.4%) | 4 (2.9%) |
Table 3 Patient characteristics distributed per extent and outcome of evaluation of their potential living donors presented as total patients (n = 212) and as a comparison between patients with candidate (n = 74) and patients with non-candidate (n = 138) potential living donors.
Characteristics | Total patients, n = 212 | Patients with candidate PLDs, n = 74 | Patients with non-candidate PLDs, n = 138 | P value |
mean ± SD (range)/number (%) | ||||
Patients per extent of evaluation of their PLDs1, n = 212 | ||||
Completed 1 | 71 (33.5%) | 54 (73%) | 17 (12.3%) | < 0.001 |
Completed 1/incomplete 1 | 15 (7.1%) | 7 (9.5%) | 8 (5.8%) | |
Completed 1/incomplete 2 | 2 (0.9%) | 2 (2.7%) | 0 (0%) | |
Completed 1/not evaluated 1 | 7 (3.3%) | 6 (8.1%) | 1 (0.7%) | |
Completed 2 | 3 (1.4%) | 3 (4.1%) | 0 (0%) | |
Completed 2/incomplete 1 | 1 (0.5%) | 0 (0%) | 1 (0.7%) | |
Completed 3 | 2 (0.9%) | 2 (2.7%) | 0 (0%) | |
Incomplete 1 | 94 (44.3%) | 0 (0%) | 94 (68.1%) | |
Incomplete 1/not evaluated 1 | 1 (0.5%) | 0 (0%) | 1 (0.7%) | |
Incomplete 1/not evaluated 2 | 1 (0.5%) | 0 (0%) | 1 (0.7%) | |
Incomplete 2 | 13 (6.1%) | 0 (0%) | 13 (9.4%) | |
Incomplete 3 | 2 (0.9%) | 0 (0%) | 2 (1.5%) | |
Patients per acceptance of their PLDs1, n = 212 | ||||
Accepted 1 | 44 (20.6%) | 44 (59.5%) | 0 (0%) | < 0.001 |
Accepted 1/excluded 1 | 8 (3.8%) | 8 (10.8%) | 0 (0%) | |
Accepted 1/excluded 2 | 2 (0.9%) | 2 (2.7%) | 0 (0%) | |
Accepted 1/not evaluated 1 | 4 (1.9%) | 4 (5.4%) | 0 (0%) | |
Excluded 1 | 81 (38.2%) | 0 (0%) | 81 (0%) | |
Excluded 2 | 14 (6.6%) | 0 (0%) | 14 (10.1%) | |
Excluded 3 | 2 (0.9%) | 0 (0%) | 2 (1.5%) | |
Excluded 1/released 1 | 5 (2.4%) | 1 (1.4%) | 4 (2.9%) | |
Excluded 1/regressed 1 | 3 (1.4%) | 1 (1.4%) | 2 (1.5%) | |
Excluded 1/not evaluated 1 | 2 (0.9%) | 0 (0%) | 2 (1.5%) | |
Excluded 1/not evaluated 2 | 1 (0.5%) | 0 (0%) | 1 (0.7%) | |
Excluded 2/released 1 | 2 (0.9%) | 1 (1.4%) | 1 (0.7%) | |
Excluded 2/regressed 1 | 1 (0.5%) | 1 (1.4%) | 0 (0%) | |
Released 1 | 28 (13.2%) | 7 (9.5%) | 21 (15.2%) | |
Released 1/not evaluated 1 | 2 (0.9%) | 2 (2.7%) | 0 (0%) | |
Regressed 1 | 12 (5.7%) | 3 (4.1%) | 9 (6.5%) | |
Regressed 2 | 1 (0.5%) | 0 (0%) | 1 (0.7%) |
Table 4 Patients distributed per characteristics of exclusion of their potential living donors presented as total patients (n = 212) and as a comparison between patients with candidate (n = 74) and patients with non-candidate (n = 138) potential living donors.
Characteristics | Total patients, n = 212 | Patients with candidate PLDs, n = 74 | Patients with non-candidate PLDs, n = 138 | P value |
mean ± SD (range)/number (%) | ||||
Patients per number of excluded PLDs, n = 121 | ||||
Patients with one excluded PLD | 100 (82.6%) | 10 (71.4%) | 90 (84.1%) | 0.764 |
Patients with two excluded PLDs | 19 (15.7%) | 4 (28.6%) | 15 (14.0%) | |
Patients with three excluded PLDs | 2 (1.7%) | 0 (0%) | 2 (1.9%) | |
Patients per causes of exclusion of their PLDs, n = 1211 | ||||
Combined immunological and medical causes | 14 (11.6%) | 3 (21.4%) | 11 (10.3%) | 0.680 |
HLA-incompatibility | 24 (19.8%) | 3 (21.4%) | 21 (19.6%) | |
ABO-incompatibility | 20 (16.5%) | 1 (7.1%) | 19 (17.8%) | |
ABO and HLA-incompatibility | 2 (1.7%) | 0 (0%) | 2 (1.9%) | |
Age | 8 (6.6%) | 0 (0%) | 8 (7.5%) | |
Diabetes mellitus | 4 (3.3%) | 0 (0%) | 4 (3.7%) | |
HCV positive | 5 (4.1%) | 2 (14.3%) | 3 (2.8%) | |
Hypertension | 11 (9.1%) | 4 (28.6%) | 7 (6.5%) | |
Leprosy | 1 (0.8%) | 0 (0%) | 1 (0.9%) | |
Low GFR | 4 (3.3%) | 1 (7.1%) | 3 (2.8%) | |
High potential recurrence of primary kidney disease | 6 (5.0%) | 0 (0%) | 6 (5.6%) | |
Proteinuria | 12 (9.9%) | 0 (0%) | 12 (11.2%) | |
Psoriasis | 1 (0.8%) | 0 (0%) | 1 (0.9%) | |
Rheumatoid arthritis | 1 (0.8%) | 0 (0%) | 1 (0.9%) | |
Urolithiasis | 5 (4.1%) | 0 (0%) | 5 (4.7%) | |
Financial causes | 3 (2.5%) | 0 (0%) | 3 (2.8%) | |
Patients per main category of causes of exclusion of their PLDs, n = 121 | ||||
Combined immunological and medical causes | 14 (11.6%) | 3 (21.4%) | 11 (10.3%) | 0.866 |
Immunologic mismatches | 46 (38%) | 4 (28.6%) | 42 (39.3%) | |
Medical causes | 58 (47.9%) | 7 (50.0%) | 51 (47.7%) | |
Financial causes | 3 (2.5%) | 0 (0%) | 3 (2.8%) | |
Patients per timing of PLDs regression, n = 18 | ||||
During evaluation | 13 (72.2%) | 0 (0%) | 13 (100.0%) | NA |
After evaluation | 5 (27.8%) | 5 (100.0%) | 0 (0%) | |
Patients per cause of release of PLDs, n = 37 | ||||
Patient death | 4 (10.8%) | 3 (27.3%) | 1 (3.9%) | 0.186 |
Patient regression | 22 (59.5%) | 6 (54.5%) | 16 (61.5%) | |
Patient non-candidacy | 11 (29.7%) | 2 (18.2%) | 9 (34.6%) | |
Patients per timing of release of PLDs, n = 37 | ||||
During evaluation | 26 (70.3%) | 0 (0%) | 26 (100.0%) | NA |
After evaluation | 11 (29.7%) | 11 (100.0%) | 0 (0%) | |
Fate of patients with evaluated PLDs, n = 212 | ||||
Transplantation in our center | 58 (27.4%) | 58 (78.4%) | 0 (0%) | NA |
Transplantation in another center | 14 (6.6%) | 1 (1.4%) | 13 (9.4%) | 0.024 |
On hemodialysis | 122 (57.6%) | 12 (16.2%) | 110 (79.7%) | < 0.001 |
Death | 9 (4.2%) | 3 (4.1%) | 6 (4.4%) | 0.920 |
Unknown | 9 (4.2%) | 0 (0%) | 9 (6.5%) | 0.024 |
Table 5 Characteristics of potential living donors presented as total (n = 257) and as a comparison between the candidate (n = 74) and non-candidate (n = 183) groups of donors
Characteristics | Total PLDs, n = 257 | Candidate PLDs, n = 74 | Non-candidate PLDs, n = 183 | P value |
mean ± SD (range)/number (%) | ||||
Mean age in yr | 40.5 ± 10.4 (18-65) | 41.0 ± 10.5 (21-60) | 40.4 ± 10.5 (18-65) | 0.498 |
Sex | ||||
Female | 169 (65.8%) | 49 (66.2%) | 120 (65.6%) | > 0.999 |
Male | 88 (34.2%) | 25 (33.8%) | 63 (34.4%) | |
Form of relatedness1 | ||||
Aunt | 4 (1.6%) | 4 (5.4%) | 0 (0%) | 0.286 |
Brother | 51 (19.8%) | 14 (18.9%) | 37 (20.2%) | |
Cousin | 4 (1.6%) | 0 (0%) | 4 (2.2%) | |
Daughter | 4 (1.6%) | 1 (1.4%) | 3 (1.6%) | |
Father | 23 (8.9%) | 7 (9.5%) | 16 (8.7%) | |
Husband | 6 (2.3%) | 2 (2.7%) | 4 (2.2%) | |
Mother | 76 (29.6%) | 23 (31.1%) | 53 (29%) | |
Nephew | 1 (0.4%) | 0 (0%) | 1 (0.6%) | |
Sister | 53 (20.6%) | 13 (17.6%) | 40 (21.9%) | |
Son | 4 (1.6%) | 1 (1.4%) | 3 (1.6%) | |
Uncle | 1 (0.4%) | 1 (1.4%) | 0 (0%) | |
Wife | 30 (11.7%) | 8 (10.8%) | 22 (12.0%) | |
Degree of relatedness | ||||
First | 143 (55.6%) | 42 (56.8%) | 101 (55.2%) | 0.020 |
Second | 104 (40.5%) | 27 (36.5%) | 77 (42.1%) | |
Third | 6 (2.3%) | 5 (6.8%) | 1 (0.6%) | |
Fourth | 4 (1.6%) | 0 (0%) | 4 (2.2%) | |
Extent of evaluation | ||||
Complete | 109 (42.4%) | 74 (100.0%) | 35 (19.1%) | NA |
Incomplete | 148 (57.6%) | 0 (0%) | 148 (80.9%) | |
Fate of PLDs | ||||
Donated | 58 (22.6%) | 58 (78.4%) | 0 (0%) | NA |
Excluded | 144 (56.0%) | 0 (0%) | 144 (78.7%) | NA |
Regressed2 | 18 (7.0%) | 5 (6.8%) | 13 (31.6%) | |
During evaluation | 13 (72.2%) | 0 (0%) | 13 (100.0%) | NA |
After evaluation | 5 (27.8%) | 5 (100%) | 0 (0%) | |
Released | 37 (14.4%) | 11 (14.9%) | 26 (68.4%) | |
Causes of donor release | ||||
Patient death | 4 (10.8%) | 3 (27.3%) | 1 (3.9%) | 0.186 |
Patient regression | 22 (59.5%) | 6 (54.5%) | 16 (61.5%) | |
Patient non-candidacy | 11 (29.7%) | 2 (18.2%) | 9 (34.6%) | |
Timing of PLDs release | ||||
During evaluation | 26 (70.3%) | 0 (0%) | 26 (100.0%) | NA |
After evaluation | 11 (29.7%) | 11 (100.0%) | 0 (0%) | |
Time spent in PLDs evaluation in mo | 2.2 ± 1.5 (0.5-6.0) | 4.0 ± 0.9 (1-6) | 1.5 ± 1.2 (0.5-5.0) | < 0.001 |
Table 6 Multivariate logistic regression of the potential variables influencing the candidacy of potential living donors with a completed preparation
Variables | Modality | Odds ratio | P value |
Dialysis status | Preemptive vs on dialysis | 0.66 (0.23-1.94) | 0.451 |
Number of potential donors | Single vs multiple | 1.69 (0.87-3.28) | 0.123 |
Donor age | Increasing age | 1.0 (0.97-1.03) | 0.925 |
Donor sex | Men vs women | 1.02 (0.55-1.92) | 0.940 |
Relatedness degree | First vs more than first | 1.07 (0.55-2.1) | 0.834 |
- Citation: Gadelkareem RA, Abdelgawad AM, Mohammed N, Reda A, Azoz NM, Zarzour MA, Hammouda HM, Khalil M. Reasons and effects of the decline of willing related potential living kidney donors. World J Transplant 2023; 13(5): 276-289
- URL: https://www.wjgnet.com/2220-3230/full/v13/i5/276.htm
- DOI: https://dx.doi.org/10.5500/wjt.v13.i5.276